(Q27313215)
Statements
Calcineurin inhibition at the clinical phase of prion disease reduces neurodegeneration, improves behavioral alterations and increases animal survival (English)
0 references
2010
0 references
6
0 references
10
0 references
e1001138
0 references
7 October 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference